oxymatrine has been researched along with Psoriasis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Groma, G | 1 |
Huang, X; Li, Q; Mei, Z; Tu, C; Wang, W; Xiang, X; Xiong, H; Zhao, Z | 1 |
Chen, Q; Chi, M; Deng, X; Leavesley, D; Shi, H; Xie, N; Xie, Y; Yang, Y; Zhang, H; Zhou, H | 1 |
Bo, KP; Gao, Q; Ma, AL; Ma, W; Shi, HJ; Song, HB; Wang, L; Zhang, N; Zhou, H | 1 |
Bo, KP; Chen, WG; Ma, W; Shi, HJ; Song, HB; Xia, L; Yang, J; Zhou, H | 1 |
2 trial(s) available for oxymatrine and Psoriasis
Article | Year |
---|---|
Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis.
Topics: Acitretin; Adult; Alkaloids; Apoptosis; Biopsy; Cell Proliferation; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Keratinocytes; Male; Psoriasis; Quinolizines; Severity of Illness Index; Skin; Treatment Outcome; Young Adult | 2019 |
Efficacy of oxymatrine for treatment and relapse suppression of severe plaque psoriasis: results from a single-blinded randomized controlled clinical trial.
Topics: Acitretin; Adult; Alkaloids; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Keratolytic Agents; Male; Psoriasis; Quality of Life; Quinolizines; Secondary Prevention; Single-Blind Method; Treatment Outcome | 2017 |
3 other study(ies) available for oxymatrine and Psoriasis
Article | Year |
---|---|
Oxymatrine may represent an additional therapeutic tool in severe plaque psoriasis management.
Topics: Alkaloids; Apoptosis; Cell Proliferation; Humans; Psoriasis; Quinolizines | 2019 |
Oxymatrine ameliorates imiquimod-induced psoriasis pruritus and inflammation through inhibiting heat shock protein 90 and heat shock protein 60 expression in keratinocytes.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Chaperonin 60; Disease Models, Animal; Down-Regulation; HaCaT Cells; HSP90 Heat-Shock Proteins; Humans; Imiquimod; Keratinocytes; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Protein Binding; Pruritus; Psoriasis; Quinolizines | 2020 |
Investigating the potential of Oxymatrine as a psoriasis therapy.
Topics: Adolescent; Adult; Aged; Alkaloids; Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Cells, Cultured; Female; Gene Expression Regulation; Humans; Keratinocytes; Male; Membrane Proteins; Middle Aged; Models, Biological; Psoriasis; Quinolizines; Retrospective Studies; Skin | 2017 |